Search results
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 18 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna Has Big AI News. Is the Stock a Buy?
The Motley Fool via AOL· 6 days agoModerna (NASDAQ: MRNA) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 2 days agoThe past two-and-a-half years have been rough for Moderna (NASDAQ: MRNA). Though the biotech was...
Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 43% Discount?
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights The projected fair value for Moderna is US$294 based on 2 Stage Free Cash Flow to...
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 5 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 5 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
The Joplin Globe· 6 days agoModerna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT
Why Vaccine Stocks Rallied This Week
The Motley Fool via AOL· 4 days agoShares of vaccine stocks Moderna (NASDAQ: MRNA), Novavax (NASDAQ: NVAX), and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and...
Why is Moderna stock up 10% on Wednesday?
Invezz· 6 days agoModerna Inc (NASDAQ: MRNA) is up more than 10% on Wednesday after a child tested positive for avian influenza in Australia. Are you looking for signals &...
Moderna director Afeyan sells over $2.3 million in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a portion of his holdings in the...